- Home
- CGON vs PACS Comparison
CGON vs PACS Comparison
Compare CGON & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- PACS
- Stock Information
- Founded
- CGON 2010
- PACS 2013
- Country
- CGON United States
- PACS United States
- Employees
- CGON N/A
- PACS N/A
- Industry
- CGON
- PACS
- Sector
- CGON
- PACS
- Exchange
- CGON NYSE
- PACS Nasdaq
- Market Cap
- CGON 1.3B
- PACS 1.5B
- IPO Year
- CGON 2024
- PACS 2024
- Fundamental
- Price
- CGON $20.64
- PACS $9.26
- Analyst Decision
- CGON Strong Buy
- PACS Strong Buy
- Analyst Count
- CGON 10
- PACS 9
- Target Price
- CGON $65.11
- PACS $33.22
- AVG Volume (30 Days)
- CGON 1.3M
- PACS 596.9K
- Earning Date
- CGON 05-08-2025
- PACS 05-16-2025
- Dividend Yield
- CGON N/A
- PACS N/A
- EPS Growth
- CGON N/A
- PACS 82.80
- EPS
- CGON N/A
- PACS 0.68
- Revenue
- CGON $1,139,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- CGON N/A
- PACS $30.39
- Revenue Next Year
- CGON $16,237.24
- PACS $15.23
- P/E Ratio
- CGON N/A
- PACS $13.60
- Revenue Growth
- CGON 461.08
- PACS 205.08
- 52 Week Low
- CGON $14.80
- PACS $8.87
- 52 Week High
- CGON $46.99
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- PACS N/A
- Support Level
- CGON $19.47
- PACS N/A
- Resistance Level
- CGON $20.63
- PACS N/A
- Average True Range (ATR)
- CGON 2.07
- PACS 0.00
- MACD
- CGON 0.20
- PACS 0.00
- Stochastic Oscillator
- CGON 48.59
- PACS 0.00
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.